Physician profile
Amir Salem
NPI 1326487513
$3,191.83
in general payments reported to CMS, 2019-2025
14 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $1,618 · 2021: $330 · 2022: $421 · 2023: $38.03 · 2024: $131 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,571.00 | 2019-2025 | Diamondback Peripheral |
| Medtronic Vascular, INC. | $294.40 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $277.89 | 2020 | |
| Merz North America, INC. | $164.67 | 2022 | |
| Philips North America LLC | $135.32 | 2019-2023 | |
| Nevro Corp. | $135.11 | 2022 | |
| Cook Medical LLC | $133.41 | 2021 | |
| Boston Scientific Corporation | $131.06 | 2019-2025 | Varithena Administration Pack |
| Surmodics, INC. | $130.99 | 2024 | Pounce LP Thrombectomy, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Curonix LLC | $113.30 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Allergan, INC. | $48.31 | 2022 | |
| Biotronik INC. | $26.62 | 2022 | |
| Avanir Pharmaceuticals, INC. | $14.95 | 2019 | |
| Argon Medical Devices, INC. | $14.80 | 2023 | Cleaner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Salem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.